Recursion Pharmaceuticals (RXRX) surged 8.31% on Friday to close at $4.17 per share, driven by bargain-hunting investors and market optimism on a potential interest rate cut. Federal Reserve Bank of New York President John Williams’ dovish comments further fueled hope for a rate adjustment. However, RXRX reported dismal Q3 earnings with a widened net loss and an 80% revenue decline. Investors are advised to consider other AI stocks for higher returns.

Read more at Yahoo Finance: Recursion (RXRX) Jumps 8% on Bargain-Hunting